Octyl gallate
Code | Size | Price |
---|
TAR-T2S1865-100mg | 100mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2S1865-1mL | 1 mL * 10 mM (in DMSO) | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
1. Octyl Gallate is an antioxidant approved by the US Food and Drug Administration (FDA) as a food additive. 2. Octyl Gallate has antimetastatic activity. 3. Octyl Gallate shows antimicrobial activity against H. pylori, with a minimum inhibitory concentration (MIC) value of 125 ug/mL. 4. Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease.5. Octyl Gallate is a potential anticancer agent, it exhibited decreased MCF-7 & MDA-MB-231 survival and induced apoptosis, with IC50 value of 40 uM. 6. Octyl gallate has antiviral activity, it shows an inhibitory effect on the growth of herpes simplex virus type 1 (HSV-1) in HEp-2 or Vero cells. 7. Octyl gallate shows antifungal activity against Saccharomyces cerevisiae ATCC7754 and Zygosaccharomyces bailii ATCC 60483.
CAS:
1034-01-1
Formula:
C15H22O5
Molecular Weight:
282.336
Pathway:
Immunology/Inflammation; NF-κb; Metabolism; oxidation-reduction; Microbiology/Virology
Purity:
0.995
SMILES:
CCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1
Target:
Antioxidant; Influenza Virus; Reactive Oxygen Species; Antibacterial; Antifungal; HSV
References
1. Sales, SM , Roy, A , Antony, L , et al. Octyl gallate and gallic acid isolated from, Terminalia bellarica, regulates normal cell cycle in human breast cancer cell lines[J]. Biomedicine & Pharmacotherapy, 2018, 103:1577-1584.